Ramy Sayed

NPI: 1518398437
Total Payments
$11,222
2024 Payments
$3,578
Companies
56
Transactions
714
Medicare Patients
2,997
Medicare Billing
$368,821

Payment Breakdown by Category

Food & Beverage$11,203 (99.8%)
Education$19.66 (0.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $11,203 712 99.8%
Education $19.66 2 0.2%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $1,597 115 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,016 54 $0 (2024)
ABBVIE INC. $788.20 54 $0 (2024)
Lilly USA, LLC $669.79 55 $0 (2024)
Esperion Therapeutics, Inc. $478.88 29 $0 (2024)
Otsuka America Pharmaceutical, Inc. $476.02 23 $0 (2024)
PFIZER INC. $463.64 38 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $459.81 27 $0 (2024)
Novartis Pharmaceuticals Corporation $422.93 26 $0 (2024)
GlaxoSmithKline, LLC. $405.50 28 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,578 218 Amgen Inc. ($386.63)
2023 $2,543 147 AbbVie Inc. ($294.02)
2022 $1,614 96 Novo Nordisk Inc ($396.26)
2021 $986.94 66 Novo Nordisk Inc ($240.11)
2020 $982.80 66 AstraZeneca Pharmaceuticals LP ($217.57)
2019 $882.64 76 PFIZER INC. ($165.16)
2018 $635.91 45 Novo Nordisk Inc ($122.34)

All Payment Transactions

714 individual payment records from CMS Open Payments — Page 1 of 29

Date Company Product Nature Form Amount Type
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $20.93 General
Category: Gastroenterology
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $19.45 General
Category: Gastroenterology
12/20/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $19.83 General
Category: ANTILIPEMIC AGENTS
12/19/2024 Intra-Sana Laboratories RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG Food and Beverage In-kind items and services $21.42 General
Category: GALLSTONES
12/16/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $16.00 General
Category: Cardio-renal
12/16/2024 Currax Pharmaceuticals LLC CONTRAVE (Drug) Food and Beverage In-kind items and services $1.90 General
Category: Obesity
12/13/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.85 General
Category: NEUROSCIENCE
12/11/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $16.95 General
Category: ENDOCRINOLOGY
12/10/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.89 General
Category: RESPIRATORY
12/06/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $14.62 General
Category: NEUROSCIENCE
12/05/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $19.69 General
Category: Obesity
12/04/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $14.83 General
Category: Cardiology/Vascular Diseases
12/04/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $14.51 General
Category: Inflammation
12/03/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $14.65 General
Category: Cardio-renal
12/02/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $22.94 General
Category: Oncology
12/02/2024 Currax Pharmaceuticals LLC CONTRAVE (Drug) Food and Beverage In-kind items and services $10.15 General
Category: Obesity
11/25/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $18.60 General
Category: Biological
11/21/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $15.86 General
Category: ANTILIPEMIC AGENTS
11/21/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $13.46 General
Category: Inflammation/Rare Disease
11/19/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $26.77 General
Category: NEUROSCIENCE
11/19/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $8.68 General
Category: Diabetes
11/18/2024 Currax Pharmaceuticals LLC CONTRAVE (Drug) Food and Beverage In-kind items and services $7.85 General
Category: Obesity
11/17/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $24.40 General
Category: Respiratory
11/14/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $7.42 General
Category: Diabetes
11/12/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $18.13 General
Category: Cardio-renal

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 20 839 1,753 $456,429 $109,754
2022 21 932 1,819 $282,750 $107,506
2021 16 586 1,102 $176,881 $69,996
2020 20 640 1,160 $218,481 $81,566
Total Patients
2,997
Total Services
5,834
Medicare Billing
$368,821
Procedure Codes
77

All Medicare Procedures & Services

77 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 232 598 $184,045 $48,808 26.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 128 128 $63,090 $15,519 24.6%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 27 137 $59,351 $12,282 20.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 28 36 $21,089 $4,464 21.2%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 15 15 $17,870 $4,229 23.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 15 68 $14,270 $4,068 28.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 39 39 $18,233 $3,896 21.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 56 64 $13,274 $3,311 24.9%
90662 Influenza vaccine split virus, preservative free Office 2023 44 44 $11,088 $3,165 28.5%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 12 12 $8,763 $1,862 21.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 21 23 $10,555 $1,842 17.4%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 19 30 $9,001 $1,826 20.3%
G0008 Administration of influenza virus vaccine Office 2023 48 48 $4,756 $1,337 28.1%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 27 32 $7,251 $1,246 17.2%
20610 Aspiration and/or injection of fluid from large joint Office 2023 15 21 $6,061 $857.52 14.1%
96372 Injection of drug or substance under skin or into muscle Office 2023 36 48 $4,724 $452.79 9.6%
G0009 Administration of pneumococcal vaccine Office 2023 13 13 $1,346 $369.72 27.5%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 19 136 $1,093 $104.69 9.6%
81002 Urinalysis, manual test Office 2023 24 28 $439.88 $95.48 21.7%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 21 233 $128.19 $19.84 15.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 190 514 $101,258 $42,165 41.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 110 110 $34,320 $13,637 39.7%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 30 129 $24,897 $9,653 38.8%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2022 30 30 $25,890 $8,356 32.3%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 49 49 $22,834 $7,606 33.3%

About Ramy Sayed

Ramy Sayed is a Pediatrics healthcare provider based in Smyrna, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/03/2013. The National Provider Identifier (NPI) number assigned to this provider is 1518398437.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ramy Sayed has received a total of $11,222 in payments from pharmaceutical and medical device companies, with $3,578 received in 2024. These payments were reported across 714 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($11,203).

As a Medicare-enrolled provider, Sayed has provided services to 2,997 Medicare beneficiaries, totaling 5,834 services with total Medicare billing of $368,821. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.

Practice Information

  • Specialty Pediatrics
  • Other Specialties Internal Medicine
  • Location Smyrna, TN
  • Active Since 12/03/2013
  • Last Updated 11/17/2025
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1518398437

Products in Payments

  • FARXIGA (Drug) $608.01
  • REXULTI (Drug) $515.28
  • Ozempic (Drug) $506.37
  • Saxenda (Drug) $484.01
  • NEXLETOL (Drug) $478.88
  • JARDIANCE (Drug) $413.79
  • MOUNJARO (Drug) $377.78
  • VRAYLAR (Drug) $376.36
  • XARELTO (Drug) $333.94
  • TRINTELLIX (Drug) $323.30
  • CeQur Simplicity (Device) $313.77
  • TRELEGY ELLIPTA (Drug) $275.62
  • CONTRAVE (Drug) $263.92
  • XIFAXAN (Drug) $254.52
  • Otezla (Drug) $236.19
  • ENTRESTO (Drug) $234.24
  • BREZTRI (Drug) $224.19
  • Kerendia (Drug) $209.81
  • LEQVIO (Drug) $188.69
  • Rybelsus (Drug) $170.05

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Smyrna